Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy

There are multiple neurological complications of cancer and its treatment. This study assessed the utility of the novel non-invasive ophthalmic technique of corneal confocal microscopy in identifying neuropathy in patients with upper gastrointestinal cancer before and after platinum based chemotherapy. In this study, 21 subjects with upper gastrointestinal (oesophageal or gastric) cancer and 21 healthy control subjects underwent assessment of neuropathy using the neuropathy disability score, quantitative sensory testing for vibration perception threshold, warm and cold sensation thresholds, cold and heat induced pain thresholds, nerve conduction studies and corneal confocal microscopy. Patients with gastro-oesophageal cancer had higher heat induced pain (P = 0.04) and warm sensation (P = 0.03) thresholds with a significantly reduced sural sensory (P<0.01) and peroneal motor (P<0.01) nerve conduction velocity, corneal nerve fibre density (CNFD), nerve branch density (CNBD) and nerve fibre length (CNFL) (P<0.0001). Furthermore, CNFD correlated significantly with the time from presentation with symptoms to commencing chemotherapy (r = -0.54, P = 0.02), and CNFL (r = -0.8, P<0.0001) and CNBD (r = 0.63, P = 0.003) were related to the severity of lymph node involvement. After the 3rd cycle of chemotherapy, there was no change in any measure of neuropathy, except for a significant increase in CNFL (P = 0.003). Corneal confocal microscopy detects a small fibre neuropathy in this cohort of patients with upper gastrointestinal cancer, which was related to disease severity. Furthermore, the increase in CNFL after the chemotherapy may indicate nerve regeneration.

[1]  G. Lauria,et al.  Small fibre neuropathy , 2017, Current opinion in neurology.

[2]  Saranya Chumsri,et al.  Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience , 2014, SpringerPlus.

[3]  G. Cavaletti Chemotherapy‐induced peripheral neurotoxicity (CIPN): what we need and what we know , 2014, Journal of the peripheral nervous system : JPNS.

[4]  Y. T. Cheung,et al.  Management options for established chemotherapy-induced peripheral neuropathy , 2014, Supportive Care in Cancer.

[5]  X. Navarro,et al.  Assessment of sensory thresholds and nociceptive fiber growth after sciatic nerve injury reveals the differential contribution of collateral reinnervation and nerve regeneration to neuropathic pain , 2014, Experimental Neurology.

[6]  F. Mols,et al.  Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review , 2014, Supportive Care in Cancer.

[7]  Xin Chen,et al.  Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. , 2014, Investigative ophthalmology & visual science.

[8]  J. Mefford,et al.  Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance) , 2014, The Pharmacogenomics Journal.

[9]  O. Lennon,et al.  Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice , 2014, Irish Journal of Medical Science.

[10]  H. Openshaw,et al.  Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin , 2013, American journal of clinical oncology.

[11]  R. Dana,et al.  Corneal innervation as a window to peripheral neuropathies. , 2013, Experimental eye research.

[12]  A. Wotherspoon,et al.  Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial , 2013, The Lancet. Oncology.

[13]  Mitra Tavakoli,et al.  Corneal confocal microscopy detects small‐fiber neuropathy in Charcot–Marie–Tooth disease type 1A patients , 2012, Muscle & nerve.

[14]  M. Rosenfeld,et al.  Paraneoplastic neurologic disorders: a brief overview , 2012, memo - Magazine of European Medical Oncology.

[15]  H. Haapasalo,et al.  Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy. , 2011, Anticancer research.

[16]  M. A. Dabbah,et al.  Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging , 2011, Medical Image Anal..

[17]  Mitra Tavakoli,et al.  Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. , 2011, Journal of visualized experiments : JoVE.

[18]  D. Cornblath,et al.  Measures of chemotherapy‐induced peripheral neuropathy: a systematic review of psychometric properties , 2010, Journal of the peripheral nervous system : JPNS.

[19]  C. Macaluso,et al.  Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  C. Macaluso,et al.  Chemotherapy-associated peripheral sensory neuropathy assessed using in vivo corneal confocal microscopy. , 2010, Archives of neurology.

[21]  Nathan Efron,et al.  Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy , 2009, Experimental Neurology.

[22]  Nathan Efron,et al.  Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease , 2009, Muscle & nerve.

[23]  M. Magistris,et al.  Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy. , 2009, Archives of neurology.

[24]  Wolfgang Grisold,et al.  Chemotherapy‐induced neuropathy , 2008, Journal of the peripheral nervous system : JPNS.

[25]  A. Norman,et al.  Capecitabine and oxaliplatin for advanced esophagogastric cancer. , 2008, The New England journal of medicine.

[26]  Nathan Efron,et al.  Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.

[27]  A. Boulton,et al.  Corneal Sensitivity Is Reduced and Relates to the Severity of Neuropathy in Patients With Diabetes , 2007, Diabetes Care.

[28]  H. Haapasalo,et al.  278 INTRAEPIDERMAL NERVE FIBER DENSITY IN PATIENTS WITH CHEMOTHERAPY‐INDUCED NEUROPATHY: A PROSPECTIVE STUDY , 2007 .

[29]  P. Dougherty,et al.  Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. , 2006, Minerva anestesiologica.

[30]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[31]  R. A. Malik,et al.  Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients , 2003, Diabetologia.

[32]  C. Krarup,et al.  Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function. , 1993, Brain : a journal of neurology.

[33]  S. Britland,et al.  Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology , 1992, Pain.

[34]  W. Trojaborg,et al.  Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.